Frutarom is embarking on its ninth acquisition of 2017, as the company has announced it will acquire full ownership of Enzymotec, Israel, at a net investment of approx. US$210 million. At of the date of signing, Frutarom held approx. 19 percent of Enzymotec's shares at an average price of US$9.6 per share. Frutarom will acquire the balance of shares at US$11.9 per share. The transaction will be done via the full merger of Enzymotec into a subsidiary of Frutarom. Total Enzymotec sales in the 12 month period ended June 2017 at US$47 million. ...

Prior to the signing of the merger agreement, Frutarom had acquired, in prior transactions, approx. 19 percent of Enzymotec's issued and outstanding shares of an overall investment of approx. US$ 42 million reflecting an average price of $US 9.6 per share and announced its intention to make a tender offer for Enzymotec shares.